Effects of COVID-19 on the admissions of aneurysmal subarachnoid hemorrhage: the West Greece experience.
Coronavirus disease 19 (COVID-19)
Subarachnoid hemorrhage (SAH)
admission rate
aneurysm
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
29
12
2020
accepted:
15
03
2021
pubmed:
22
3
2021
medline:
1
6
2021
entrez:
21
3
2021
Statut:
ppublish
Résumé
Acute subarachnoid hemorrhage (SAH) due to aneurysmal rupture is a devastating vascular disease accounting for 5% of strokes. COVID-19 pandemic resulted in a decrease in elective and emergency admissions in the majority of neurosurgical centers. The main hypothesis was that fear of COVID-19 may have prevented patients with critical medical or surgical emergencies from actively presenting in emergency departments and outpatient clinics. We conducted a single-center, retrospective, observational study searching our institutional data regarding the incidence of spontaneous subarachnoid hemorrhage (SAH) and compare the admissions in two different periods: the pre COVID-19 with the COVID-19 period. The study cohort was comprised of a total of 99 patients. The mean (SD) weekly case rate of patients with SAH was 1.1 (1.1) during the pre-COVID-19 period, compared to 1.7 (1.4) during the COVID-19 period. Analysis revealed that the volume of admitted patients with SAH was 1.5-fold higher during the COVID period compared to the pre-COVID period and this was statistically significant (ExpB = 1.5, CI 95% 1-2.3, p = 0.044). Difference in mortality did not reach any statistical significance between the two periods (p = 0.097), as well as patients' length of stay (p = 0.193). The presented data cover a more extended time period than so far published reports; it is reasonable that our recent experience may well be demonstrating a general realistic trend of overall increase in aneurysmal rupture rates during lockdown. Hospitalization of patients with SAH cannot afford any reductions in facilities, equipment, or personnel if optimum outcomes are desirable.
Sections du résumé
BACKGROUND
BACKGROUND
Acute subarachnoid hemorrhage (SAH) due to aneurysmal rupture is a devastating vascular disease accounting for 5% of strokes. COVID-19 pandemic resulted in a decrease in elective and emergency admissions in the majority of neurosurgical centers. The main hypothesis was that fear of COVID-19 may have prevented patients with critical medical or surgical emergencies from actively presenting in emergency departments and outpatient clinics.
METHODS
METHODS
We conducted a single-center, retrospective, observational study searching our institutional data regarding the incidence of spontaneous subarachnoid hemorrhage (SAH) and compare the admissions in two different periods: the pre COVID-19 with the COVID-19 period.
RESULTS
RESULTS
The study cohort was comprised of a total of 99 patients. The mean (SD) weekly case rate of patients with SAH was 1.1 (1.1) during the pre-COVID-19 period, compared to 1.7 (1.4) during the COVID-19 period. Analysis revealed that the volume of admitted patients with SAH was 1.5-fold higher during the COVID period compared to the pre-COVID period and this was statistically significant (ExpB = 1.5, CI 95% 1-2.3, p = 0.044). Difference in mortality did not reach any statistical significance between the two periods (p = 0.097), as well as patients' length of stay (p = 0.193).
CONCLUSIONS
CONCLUSIONS
The presented data cover a more extended time period than so far published reports; it is reasonable that our recent experience may well be demonstrating a general realistic trend of overall increase in aneurysmal rupture rates during lockdown. Hospitalization of patients with SAH cannot afford any reductions in facilities, equipment, or personnel if optimum outcomes are desirable.
Identifiants
pubmed: 33745041
doi: 10.1007/s10072-021-05190-6
pii: 10.1007/s10072-021-05190-6
pmc: PMC7981384
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2167-2172Références
Acta Neurochir (Wien). 2020 Sep;162(9):2221-2233
pubmed: 32642834
J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1365-72
pubmed: 17470467
Neurol Sci. 2021 Mar;42(3):799-804
pubmed: 33433758
Acta Neurochir (Wien). 2020 Jul;162(7):1485-1490
pubmed: 32405671
Saudi J Anaesth. 2015 Jul-Sep;9(3):306-13
pubmed: 26240552
Surg Neurol Int. 2017 Jan 19;8:11
pubmed: 28217390
J Anaesthesiol Clin Pharmacol. 2014 Jul;30(3):328-37
pubmed: 25190938
J Neurosurg. 2016 Sep;125(3):737-45
pubmed: 26824376
Neurol Sci. 2021 Jan;42(1):15-20
pubmed: 33021704
Acta Neurochir (Wien). 2020 Jul;162(7):1501
pubmed: 32377950
World Neurosurg. 2020 Jul;139:744-745
pubmed: 32474100
Dtsch Arztebl Int. 2017 Mar 31;114(13):226-236
pubmed: 28434443
JAMA Neurol. 2019 May 1;76(5):588-597
pubmed: 30659573
Acta Neurochir (Wien). 2020 Aug;162(8):1795-1801
pubmed: 32514620
Neurol Sci. 2021 Mar;42(3):791-798
pubmed: 33428057
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
World Neurosurg. 2020 Jul;139:e864-e871
pubmed: 32450310
Acta Neurochir (Wien). 2020 Nov;162(11):2715-2724
pubmed: 32974834
J Neurosurg Sci. 2020 Aug;64(4):409-410
pubmed: 32347681
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631